...
首页> 外文期刊>Pharmacology: International Journal of Experimental and Clinical Pharmacology >Inducible nitric oxide synthase activity and expression in liver and hepatocytes of diabetic rats.
【24h】

Inducible nitric oxide synthase activity and expression in liver and hepatocytes of diabetic rats.

机译:糖尿病大鼠肝脏和肝细胞中可诱导的一氧化氮合酶活性和表达。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Inducible nitric oxide synthase (iNOS) is expressed by the liver in a number of physiological and pathophysiological conditions. The aim of this study was to investigate the relationship between the diabetic state, iNOS and oxidative stress in the rat liver and isolated hepatocytes. Hepatic iNOS expression and activity was measured in both healthy and streptozotocin-induced diabetic rats and determined in hepatocytes in the presence and absence of insulin. Cu/Zn superoxide dismutase (SOD) and phosphatidylinositol-3-kinase (PI3K) were also measured. In a separate experiment lasting 3 weeks, diabetic rats received either no treatment, two daily injections of insulin or aminoguanidine in the drinking water. Diabetes led to increased activity (45%) and expression (70%) of liver iNOS, an effect that was attenuated by insulin treatment both in vitro and in whole animals. Hepatocyte iNOS expression increased by 56%. Hepatic SOD expression was elevated in the diabetic state, but activity levels were similar tohealthy controls. Insulin treatment in vivo led to increased enzyme activity but expression was not modified. Levels of PI3K protein were significantly lower in diabetic rats while insulin treatment markedly increased expression. Aminoguanidine did not inhibit hepatic iNOS in this study. Glycemic control via insulin administration was able to downregulate enhanced hepatic iNOS activity and expression in the liver observed in the diabetic state and improve SOD activity, responses that can potentially reduce the free radical damage associated with diabetes.
机译:肝脏在许多生理和病理生理条件下都表达诱导型一氧化氮合酶(iNOS)。这项研究的目的是调查糖尿病状态,iNOS与大鼠肝脏和分离的肝细胞中氧化应激之间的关系。在健康大鼠和链脲佐菌素诱导的糖尿病大鼠中均测量了肝脏iNOS的表达和活性,并在存在和不存在胰岛素的情况下在肝细胞中测定了肝iNOS的表达和活性。还测量了铜/锌超氧化物歧化酶(SOD)和磷脂酰肌醇-3-激酶(PI3K)。在一个持续3周的单独实验中,糖尿病大鼠未接受任何治疗,每天两次在饮用水中注射胰岛素或氨基胍。糖尿病导致肝脏iNOS的活性增加(45%)和表达(70%),这种作用在体外和整个动物中都被胰岛素治疗所减弱。肝细胞iNOS表达增加了56%。在糖尿病状态下肝SOD表达升高,但活性水平与健康对照相似。体内胰岛素治疗导致酶活性增加,但表达未修饰。在糖尿病大鼠中,PI3K蛋白水平显着降低,而胰岛素治疗显着增加了表达。在这项研究中,氨基胍不抑制肝iNOS。通过胰岛素给药的血糖控制能够下调在糖尿病状态下观察到的增强的肝iNOS活性和在肝脏中的表达,并改善SOD活性,这种反应可以潜在地减少与糖尿病相关的自由基损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号